Stockscreener 앱 받기
44.05
5.98%
-2.80
시간 외 거래:
44.05
Guardant Health Inc 주식(GH)의 최신 뉴스
Guardant Health (GH): Scotiabank Raises Price Target to $57.00 | GH Stock News - GuruFocus
Genomic Cancer Testing Market Grows with Advances in Precision - openPR.com
Scotiabank Increases Guardant Health (GH) Price Target After Strong Q1 Performance | GH Stock News - GuruFocus
Guardant Health, Inc. (NASDAQ:GH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$59.17 - Yahoo Finance
Decoding Guardant Health Inc (GH): A Strategic SWOT Insight - GuruFocus
Guardant Health’s (NASDAQ:GH) Q4: Beats On Revenue - Barchart.com
Guardant Health, Inc. (NASDAQ:GH) Q1 2025 Earnings Call Transcript - Insider Monkey
Morgan Stanley Raises Price Target on Guardant Health to $60 From $52, Keeps Overweight Rating - marketscreener.com
Guardant Health (GH) Price Target Boosted by BTIG to $65 Amid St - GuruFocus
Guardant Health stock soars to 52-week high of $52.49 By Investing.com - Investing.com India
Guardant Health Reports Strong Q1 Revenue Growth - TipRanks
Guardant Health (GH) Sees Target Price Raised by TD Securities | - GuruFocus
Canaccord raises Guardant Health target to $65, maintains Buy By Investing.com - Investing.com Canada
Guardant Health (GH) Sees Price Target Raised by Canaccord Genui - GuruFocus
Guardant Health: Tailwinds Are Beginning To Impact The Financials (NASDAQ:GH) - Seeking Alpha
Guardant Health (GH) Price Target Increased Amid Positive Moment - GuruFocus
Guardant Health (GH) Receives Price Target Boost from UBS | GH S - GuruFocus
Stifel Raises Price Target for Guardant Health (GH) to $60 | GH Stock News - GuruFocus
Guardant Health (GH) Stock Target Price Raised by Barclays Analy - GuruFocus
Guardant Health (GH) Stock Target Price Raised by Barclays Analyst | GH Stock News - GuruFocus
Guardant Health (GH) Receives Price Target Increase from UBS | G - GuruFocus
Guardant Health stock soars to 52-week high of $52.49 - Investing.com
UBS Adjusts Guardant Health Price Target to $70 From $65, Maintains Buy Rating - marketscreener.com
Canaccord raises Guardant Health target to $65, maintains Buy - Investing.com
Guardant Health (GH) Price Target Boosted by BTIG to $65 Amid Strong Growth | GH Stock News - GuruFocus
Canaccord Increases Guardant Health (GH) Price Target to $65 | G - GuruFocus
Guardant Health Inc (GH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Barclays Lifts Guardant Health (GH) Price Target Amid Business G - GuruFocus
Earnings call transcript: Guardant Health Q1 2025 beats EPS forecast, revenue rises - Investing.com Nigeria
Guardant Health Q1 Adjusted Loss Widen, Revenue Rises; 2025 Revenue Guidance Raised - marketscreener.com
Guardant Health Inc (GH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo
Guardant Health Surpasses Q1 2025 Revenue ExpectationsNews and Statistics - IndexBox
Guardant Health Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance - BioSpace
Guardant Health up 4% on Q1 beats, 2025 guidance revenue raise - MSN
Guardant Health (GH) Reports Strong Q1 2025 Revenue Growth - GuruFocus
Guardant Health, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:GH) - Seeking Alpha
Guardant Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Guardant Health (GH) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Guardant Health stock jumps 6.9% on earnings beat, raised guidance By Investing.com - Investing.com Nigeria
Guardant Health Inc (GH) Q1 2025 Earnings: EPS Loss of $0.77 Bea - GuruFocus
Guardant Health (GH) Revises Growth Forecasts and Financial Outl - GuruFocus
Guardant Health (GH) Surpasses Revenue Expectations with Strong Q1 Performance | GH Stock News - GuruFocus
Guardant Health: Q1 Earnings Snapshot - San Francisco Chronicle
Guardant Health stock jumps 6.9% on earnings beat, raised guidance - Investing.com Australia
Guardant Health’s (NASDAQ:GH) Q1: Strong Sales, Stock Soars - Yahoo Finance
Guardant Health earnings beat by $0.26, revenue topped estimates - Investing.com
Earnings Flash (GH) Guardant Health Posts Q1 Revenue $203.5M, vs. FactSet Est of $190.1M - marketscreener.com
[Latest] Global Multi Cancer Early Detection Market Size/Share Worth USD 5.09 Billion by 2034 at a 14.85% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire
Guardant Health’s blood test shows promise for early cancer detection - Investing.com
Guardant Health Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types - 01net
Guardant Health Presents Data Demonstrating Strong Performance o - GuruFocus
0.34%
0.46%
자본화:
|
볼륨(24시간):